首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Efficacies of Cefepime Ceftazidime and Imipenem Alone or in Combination with Amikacin in Rats with Experimental Pneumonia Due to Ceftazidime-Susceptible or -Resistant Enterobacter cloacae Strains
【2h】

Note: Efficacies of Cefepime Ceftazidime and Imipenem Alone or in Combination with Amikacin in Rats with Experimental Pneumonia Due to Ceftazidime-Susceptible or -Resistant Enterobacter cloacae Strains

机译:注意:头孢吡肟敏感性或耐药性阴沟肠杆菌菌株引起的实验性肺炎大鼠中单独使用头孢吡肟头孢他啶和亚胺培南或与阿米卡星合用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The antibacterial activities of human regimens of cefepime, ceftazidime, and imipenem alone or in combination with amikacin against an isogenic pair of Enterobacter cloacae strains (wild type and its corresponding derepressed cephalosporinase mutant) were compared by using our nonlethal model of pneumonia with 180 immunocompetent rats. Compared with untreated animals, all β-lactam-treated rats, except those inoculated with the mutant isolate and receiving ceftazidime, had significantly lower bacterial counts in their lungs 60 h after the onset of therapy. Although the combination of a β-lactam and amikacin was more bactericidal than each corresponding antimicrobial agent alone, true synergy was noted only with cefepime and imipenem against the constitutive derepressed strain.
机译:使用我们的非致死性肺炎模型与180只具有免疫能力的大鼠,比较了头孢吡肟,头孢他啶和亚胺培南单独或与阿米卡星联合使用的人类方案对同基因对阴沟肠杆菌菌株(野生型及其对应的抑制的头孢菌素酶突变体)的抗菌活性。 。与未经治疗的动物相比,除接种突变分离株并接受头孢他啶的大鼠外,所有经β-内酰胺治疗的大鼠在治疗开始后60 h的肺部细菌计数均显着降低。尽管β-内酰胺和丁胺卡那霉素的组合比单独使用每种相应的抗菌剂具有更好的杀菌作用,但只有头孢吡肟和亚胺培南对组成型抑制的菌株产生真正的协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号